JM

James R. McCarthy

MP Merrell Dow Pharmaceuticals: 26 patents #6 of 237Top 3%
MP Merrell Pharmaceuticals: 8 patents #23 of 168Top 15%
EL Eli Lilly: 6 patents #569 of 2,858Top 20%
IT Indiana University Research And Technology: 4 patents #52 of 664Top 8%
The Dow Chemical: 2 patents #1,449 of 4,115Top 40%
BS Bristol-Myers Squibb: 2 patents #1,811 of 3,969Top 50%
UN Unknown: 1 patents #29,356 of 83,584Top 40%
📍 Indianapolis, IN: #20 of 5,011 inventorsTop 1%
🗺 Indiana: #135 of 33,936 inventorsTop 1%
Overall (All Time): #27,955 of 4,157,543Top 1%
72
Patents All Time

Issued Patents All Time

Showing 26–50 of 72 patents

Patent #TitleCo-InventorsDate
6133276 Compounds and methods for increasing endogenous levels of corticotropin-releasing factor Jeffrey P. Whitten, Zhengyu Liu, Charles Huang, Philip Erickson, Dominic P. Behan 2000-10-17
5977325 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives Michael L. Edwards, Donald P. Matthews 1999-11-02
5959109 Compounds and methods for increasing endogenous levels of corticotropin-releasing factor Jeffrey P. Whitten, Zhengyu Liu, Charles Huang, Philip Erickson, Dominic P. Behan 1999-09-28
5830863 Neurokinin A antagonists Stephen H. Buck, Scott L. Harbeson, John L. Krstenansky, Chester F. Hassman, III 1998-11-03
5795905 CRF receptor antagonists and methods relating thereto Yun Feng Xie, Jeffrey P. Whitten, Thomas R. Webb, Chen Chen, John Ramphal 1998-08-18
5760210 Process for the preparation of ribonucleotide reductase inhibitors Donald P. Matthews, Jeffrey S. Sabol, James R. McConnell, Richard E. Donaldson, Robert J. Duguid 1998-06-02
5616702 2-'-ethenylidene cytidine, uridine and guanosine derivatives Michael L. Edwards, Donald P. Matthews 1997-04-01
5607925 Treatment of carcinoma by administration of 2'-halomethylidenyl-2'-deoxynucleosides Donald P. Matthews, Alan J. Bitonti, Michael L. Edwards 1997-03-04
5589587 Process for the preparation of ribonucleotide reductase inhibitors Donald P. Matthews, Jeffrey S. Sabol, James R. McConnell, Richard E. Donaldson, Robert Duquid 1996-12-31
5521162 Aristeromycin analogues of 4',5'-didehydro-5'-fluoro-adenosine and methods of treating neoplastic and viral disease conditions Esa T. Jarvi, Nellikunja J. Prakash 1996-05-28
5512678 5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agents Donald P. Matthews, Jeffrey S. Sabol 1996-04-30
5508393 Process for the preparation of ribonucleotide reductase inhibitors Donald P. Matthews, Jeffrey S. Sabol, James R. McConnell, Richard E. Donaldson, Robert Duquid 1996-04-16
5473104 Process for the preparation of L-carnitine 1995-12-05
5470837 5'-vinylhalo-aristeromycin/adenosine analogs and immunosuppressants Jeffrey A. Wolos, Niall Doherty, Esa T. Jarvi 1995-11-28
5378693 2'-halomethylidene cytidine, uridine and guanosine compounds and their pharmaceutical compositions Michael L. Edwards, Donald P. Matthews 1995-01-03
5348964 Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis Charlotte L. Barney, Marion W. Wannamaker 1994-09-20
5217979 Substituted alkyl piperidines Charlotte L. Barney, Marion W. Wannamaker 1993-06-08
5189052 Thione dopamine beta hydroxylase inhibitors Donald P. Matthews, Jeffrey P. Whitten, Robert J. Broersma, Jr. 1993-02-23
5157166 Process for the preparation of di-fluro analogs of squalene Esa T. Jarvi, Michael L. Edwards 1992-10-20
5147863 2,2'-bi-1H-imidazoles Donald P. Matthews, Jeffrey P. Whitten 1992-09-15
5120764 Inhibitors of lysyl oxidase Charlotte L. Barney, Donald P. Matthews, Philippe Bey 1992-06-09
5112852 Allenyl amines Thomas M. Bargar, Charlotte L. Barney, Donald P. Matthews, Robert J. Broersma, Jr. 1992-05-12
5068465 Pharmaceutically active 3-aryl-2-fluoro-1-olefins Charlotte L. Barney, Donald P. Matthews 1991-11-26
5064864 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase Esa T. Jarvi, Michael L. Edwards 1991-11-12
5057613 Novel thione dopamine beta hydroxylase inhibitors Donald P. Matthews, Jeffrey P. Whitten, Robert J. Broersma, Jr. 1991-10-15